Eledon Pharmaceuticals Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -1,388.2% | – | -4,944.5% | – | – | – | – | – | – | – | |
| – | – | – | 17.3% | – | 22.9% | – | – | – | – | – | – | – | |
| – | – | – | 547.0% | – | 1,714.1% | – | – | – | – | – | – | – | |
| – | – | – | 564.3% | – | -395.1% | – | – | – | – | – | – | – | |
| – | – | – | 0.0% | – | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | -3,555.9% | – | -12,339.1% | – | – | – | – | – | – | – | |
| – | – | – | 8,584.1% | – | 20,876.8% | – | – | – | – | – | – | – | |
| – | – | – | 3,640.0% | – | 3,593.2% | – | – | – | – | – | – | – | |
| – | – | – | -1,388.2% | – | -4,944.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.